VANI vs. ZYXI, AXGN, OM, SMLR, EDAP, ELMD, FONR, HYPR, ECOR, and CUTR
Should you be buying Vivani Medical stock or one of its competitors? The main competitors of Vivani Medical include Zynex (ZYXI), AxoGen (AXGN), Outset Medical (OM), Semler Scientific (SMLR), Edap Tms (EDAP), Electromed (ELMD), FONAR (FONR), Hyperfine (HYPR), electroCore (ECOR), and Cutera (CUTR). These companies are all part of the "electromedical equipment" industry.
Vivani Medical (NASDAQ:VANI) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, analyst recommendations, profitability, community ranking and valuation.
Zynex has a net margin of 4.33% compared to Vivani Medical's net margin of 0.00%. Zynex's return on equity of 16.34% beat Vivani Medical's return on equity.
Zynex has a consensus price target of $18.00, indicating a potential upside of 87.70%. Given Zynex's higher possible upside, analysts clearly believe Zynex is more favorable than Vivani Medical.
In the previous week, Vivani Medical's average media sentiment score of 0.00 equaled Zynex'saverage media sentiment score.
6.8% of Vivani Medical shares are owned by institutional investors. Comparatively, 29.7% of Zynex shares are owned by institutional investors. 55.6% of Vivani Medical shares are owned by insiders. Comparatively, 52.1% of Zynex shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Zynex received 21 more outperform votes than Vivani Medical when rated by MarketBeat users. However, 100.00% of users gave Vivani Medical an outperform vote while only 51.16% of users gave Zynex an outperform vote.
Vivani Medical has a beta of 3.22, indicating that its stock price is 222% more volatile than the S&P 500. Comparatively, Zynex has a beta of 0.61, indicating that its stock price is 39% less volatile than the S&P 500.
Zynex has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.
Summary
Zynex beats Vivani Medical on 11 of the 14 factors compared between the two stocks.
Get Vivani Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for VANI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VANI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Vivani Medical Competitors List
Related Companies and Tools
